Here are relevant reports on : continuous-glucose-monitoring-devices-market
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs & Region - Global Forecast to 2029
The global patient monitoring devices market, valued at US$45.7 billion in 2022, stood at US$48.5 billion in 2024 and is projected to advance at a resilient CAGR of 8.0% from 2024 to 2029, culminating in a forecasted valuation of US$71.1 billion by the end of the period. This growth is driven by factors such as the increasing prevalence of chronic disorders, an aging population, advancements in healthcare technology, and the rising adoption of wireless monitoring devices.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018
The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
- Published: August 2013
- Price: $ 4950
- TOC Available:
-
Mercury Analyzer Market by Type (Cold Vapor Atomic Absorption and Cold Vapor Atomic Fluorescence), Monitoring Type (Continuous and Lab), End-Use Industry (Environmental Monitoring, Food Industry) and Region - Global Forecast to 2029
The mercury analyzer market is expected to grow from USD 310 million in 2024 to USD 426 million by 2029, at a compound annual growth rate (CAGR) of 6.6% during the forecast period.The key players Teledyne Leeman Labs (US), Tekran Instruments Corporation (Canada), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), Milestone Srl (US), Analytik Jena GmbH+Co. KG (Germany), Nippon Instruments Corporation (Japan), Hitachi High-Tech Corporation (Japan), Lumex Instruments (Canada), ENVEA (France).
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Gastrointestinal Products Market | Gastroenterology Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Global Forecast to 2029
The global gastrointestinal products market, valued at US$13.8 million in 2023, stood at US$14.7 million in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$19.7 million by the end of the period. Market growth can be attributed to the growing prevalence of gastrointestinal diseases such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and colorectal cancer, which drives the demand for diagnostic and therapeutic products.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Cold Chain Monitoring Market by Sensors and Data Loggers, RFID Devices, Telematics & Telemetry Devices, Networking Devices, Logistics (Storage, Transportation), Application (Pharmaceuticals & Healthcare, Food & Beverages) - Global Forecast to 2030
The global cold chain monitoring market is expected to grow from USD 8.31 billion in 2025 to USD 15.04 billion by 2030, at a compound annual growth rate (CAGR) of 12.6% during the forecast period. The Key Players Carrier (US), Testo SE & Co. KGaA (Germany), Cryoport Inc. (US), ORBCOMM (US), Controlant hf. (Iceland), Zebra Technologies Corp. (US), Xylem (US), Digi International Inc. (US), AgroFresh (US), and Rotronic AG (Switzerland).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Patient Monitoring Devices – Emerging Markets BRIC(Brazil, Russia, India, China) 2010-2015
The Emerging Markets: BRIC (Brazil, Russia, India and China) Patient Monitors witnesses significant growth opportunities due to rapidly aging population, high incidence of chronic diseases, and government initiatives such as reform in healthcare delivery systems. Despite the impact of economic slowdown, BRIC nations are expected to grow at a CAGR of around 10 - 12% from 2009 – 2014.
- Published: July 2010
- Price: $ 4950
- TOC Available:
-
Wearable Healthcare Devices Market by Product (Trackers, Smartwatch, Patches), Type (Diagnostic (Vital Sign, ECG, Glucose), Therapeutic (Pain, Insulin)), Grade (Consumer, Clinical), Channel (Online, Pharmacy), Application (RPM) - Global Forecast to 2030
The global wearable healthcare devices market, valued at US$41.07 billion in 2024, stood at US$45.29 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$75.98 billion by the end of the period. Market growth is driven by rising health awareness, a shift toward preventive care, and the increasing prevalence of chronic conditions in aging populations.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030
The global remote patient monitoring market, valued at US$24.39B in 2023, is forecasted to grow at a 12.7% CAGR, reaching US$27.72B by 2024 and US$56.94B by 2030. The key drivers behind this growth include increasing chronic diseases, home healthcare preferences, advances in wearable technology, and the digital transformation of healthcare.
- Published: February 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
